QT
MCRB icon

Quantbot Technologies’s Seres Therapeutics MCRB Stock Holding History

Quantbot Technologies’s Portfolio MCRB Stock Details MCRB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,230
Closed -$34.4K – 1782
2023
Q4 		$34.4K Sell
1,230
-1,290
-51% -$33.9K ﹤0.01% 1379
2023
Q3 		$120K Buy
+2,520
New +$192K 0.01% 1046
2022
Q1 		– Sell
-1,410
Closed -$234K – 1890
2021
Q4 		$234K Buy
+1,410
New +$224K 0.02% 689
2021
Q2 		– Sell
-105
Closed -$43K – 1696
2021
Q1 		$43K Buy
105
+65
+163% +$29.9K ﹤0.01% 1042
2020
Q4 		$19K Sell
40
-50
-56% -$29.3K ﹤0.01% 1018
2020
Q3 		$50K Buy
+90
New +$29.9K 0.01% 858
2016
Q4 		– Sell
-55
Closed -$13K – 1228
2016
Q3 		$13K Buy
55
+20
+57% +$7.02K ﹤0.01% 980
2016
Q2 		$20K Buy
+35
New +$20.5K ﹤0.01% 920

Other funds holding MCRB

FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Hudson Bay Capital Management
Hudson Bay Capital Management Stamford, Connecticut $29B AUM 30.2% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return

Quantbot Technologies's MCRB Position: Q1 2024 in Review

Quantbot Technologies sold out of Seres Therapeutics (MCRB) in Q1 2024, closing a stake of 1,230 shares — an estimated $34.4K sold.

Quantbot Technologies first reported a position in MCRB in Q2 2016 and held it in 8 quarters. The position peaked at $234K in Q4 2021. 99 funds tracked by Wall St. Rank hold MCRB as of Q1 2024.

  • Quantbot Technologies reported no remaining Seres Therapeutics position as of Q1 2024 after selling out during the quarter.
  • Quantbot Technologies sold 1,230 Seres Therapeutics shares in Q1 2024, an estimated $34.4K.
  • Quantbot Technologies first reported a position in Seres Therapeutics in Q2 2016 and held it in 8 quarters.
  • Quantbot Technologies's Seres Therapeutics position peaked at $234K in Q4 2021.
  • 99 funds tracked by Wall St. Rank held Seres Therapeutics as of Q1 2024.

Based on Quantbot Technologies's 13F filing for Q1 2024, filed 6 May 2024.